Prevention of indwelling central venous catheter sepsis

Medical and Pediatric Oncology
D DaghistaniS Toledano

Abstract

In an attempt to decrease the incidence of central venous catheter sepsis in children with cancer, we conducted a study to evaluate the benefit of adding broad-spectrum antibiotics to the catheter "flush solution." In a prospective, placebo-controlled, double-blinded, randomized trial, 69 children with different types of malignancies were studied. The central venous catheters in these children were flushed with either the standard solution (normal saline + 100 U/ml of heparin) or the study solution (25 microgram/ml of both amikacin and vancomycin added to the standard solution). At the conclusion of the study, 64 children with a total of 67 indwelling central venous lines were assessable. The total catheter days on study were 20,700 days, with a median of 323 catheter days per patient. We documented 10 events of catheter-related infections (0.49 events/1,000 catheter days at risk). Five of these events were catheter-related sepsis (0.24 sepses/1,000 catheter days): two were fungal and three were bacterial. Due to the low incidence of catheter-related sepsis in this study, no statement regarding the prophylactic use of antibiotics could be made. The extremely low rate of catheter-related sepsis reported herein may be retrospecti...Continue Reading

References

Feb 1, 1992·The Journal of Hospital Infection·A Johnson, B A Oppenheim
Aug 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·I I Raad, G P Bodey
May 1, 1991·Molecular Microbiology·T OlschlägerV Braun
Sep 1, 1990·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·C SchwartzK Powell

❮ Previous
Next ❯

Citations

May 29, 1999·International Journal of Radiation Oncology, Biology, Physics·J T FortneyS R Schulman
Sep 6, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Deborah TomlinsonLillian Sung
Apr 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Naomi P O'GradyUNKNOWN Healthcare Infection Control Practices Advisory Committee (HICPAC)
Apr 7, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Naomi P O'GradyUNKNOWN Healthcare Infection Control Practices Advisory Committee (HICPAC) (Appendix 1)
May 1, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christopher J Crnich, Dennis G Maki
Jul 14, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Nasia Safdar, Dennis G Maki
Apr 29, 2011·American Journal of Infection Control·Naomi P O'GradyUNKNOWN Healthcare Infection Control Practices Advisory Committee
Aug 19, 2007·Seminars in Oncology Nursing·Dawn Camp-Sorrell
Oct 17, 2006·Worldviews on Evidence-based Nursing·Olive Kin Eng Lee, Linda Johnston
Feb 18, 2010·Pediatric Blood & Cancer·Antonio RuggieroRiccardo Riccardi
Mar 6, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles A SchifferMark Levine
Jan 20, 2007·Intensive Care Medicine·M Angeles García-TeresaUNKNOWN Spanish Central Venous Catheter Pediatric Study Group
Sep 28, 2007·The Lancet Infectious Diseases·Issam RaadDennis Maki
Apr 16, 2004·Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society·Holly Bagnall-Reeb
Jun 16, 2006·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·A SimonK Beutel
Jul 14, 2016·The Cochrane Database of Systematic Reviews·Nai Ming LaiKenneth Tan
Jun 27, 2013·The Cochrane Database of Systematic Reviews·Reineke A SchootMarianne D van de Wetering
Oct 11, 2014·The Cochrane Database of Systematic Reviews·Eduardo López-BrizAmanda Burls
Apr 29, 2005·Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies·Rogier C J de JongeReinoud J B J Gemke
Nov 28, 2013·The Cochrane Database of Systematic Reviews·Marianne D van de WeteringTheresa A Lawrie
Feb 25, 2003·Cancer Control : Journal of the Moffitt Cancer Center·Gianluigi FerrettiSandro Barni
Nov 26, 1997·Medical and Pediatric Oncology·E CastagnolaL Massimo
Apr 16, 2003·British Journal of Haematology·Elio CastagnolaClaudio Viscoli
Feb 14, 2004·Haemophilia : the Official Journal of the World Federation of Hemophilia·L A ValentinoM M Wilkes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Candidiasis (ASM)

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candidiasis

Candidiasis is a common fungal infection caused by Candida and it can affect many parts for the body including mucosal membranes as well as the gastrointestinal, urinary, and respiratory tracts. Here is the latest research.

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Candida albicans

Candida albicans is an opportunistic, fungal pathogen of humans that frequently causes superficial infections of oral and vaginal mucosal surfaces of debilitated and susceptible individuals. Discover the latest research on Candida albicans here.